UPDATED Apr 11, 2024
Companys with strong funding and high growth potential
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2315 | HK$6.12 | -22.3% | -76.0% | HK$2.4b | HK$15.39 | PS3.1x | E100.1% | n/a | Pharmaceuticals & Biotech | ||
6185 | HK$18.34 | 7.4% | -57.4% | HK$8.8b | HK$26.33 | PS11.7x | E124.2% | 0% | Pharmaceuticals & Biotech | ||
6185 | HK$18.34 | 7.4% | -57.4% | HK$8.8b | HK$26.33 | PS11.7x | E124.2% | 0% | Pharmaceuticals & Biotech | ||
1952 | HK$25.60 | 11.3% | 55.2% | HK$8.2b | HK$28.05 | PS60x | E80.2% | n/a | Pharmaceuticals & Biotech | ||
1952 | HK$25.60 | 11.3% | 55.2% | HK$8.2b | HK$28.05 | PS60x | E80.2% | n/a | Pharmaceuticals & Biotech | ||
6185 | HK$18.34 | 7.4% | -57.4% | HK$8.8b | HK$26.33 | PS11.7x | E124.2% | 0% | Pharmaceuticals & Biotech | ||
1952 | HK$25.60 | 11.3% | n/a | HK$8.2b | HK$28.05 | PS60x | E80.2% | n/a | Pharmaceuticals & Biotech | ||
6160 | US$88.55 | -4.4% | -44.8% | US$15.6b | US$158.84 | PS6.4x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
6160 | US$88.55 | -4.4% | -44.8% | US$15.6b | US$158.84 | PS6.4x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
6160 | US$88.55 | -4.4% | -44.8% | US$15.6b | US$158.84 | PS6.4x | E56.5% | n/a | Pharmaceuticals & Biotech |